9-135624512-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182974.3(GLT6D1):c.416C>T(p.Thr139Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182974.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLT6D1 | NM_182974.3 | c.416C>T | p.Thr139Ile | missense_variant | 5/5 | ENST00000371763.6 | NP_892019.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLT6D1 | ENST00000371763.6 | c.416C>T | p.Thr139Ile | missense_variant | 5/5 | 1 | NM_182974.3 | ENSP00000360829.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249412Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135348
GnomAD4 exome AF: 0.0000335 AC: 49AN: 1461814Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 727204
GnomAD4 genome AF: 0.000276 AC: 42AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2021 | The c.416C>T (p.T139I) alteration is located in exon 5 (coding exon 4) of the GLT6D1 gene. This alteration results from a C to T substitution at nucleotide position 416, causing the threonine (T) at amino acid position 139 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at